115 related articles for article (PubMed ID: 16044578)
21. Tenofovir and changes in renal function.
Gupta SK
Clin Infect Dis; 2005 Aug; 41(4):570-1; author reply 571. PubMed ID: 16028175
[No Abstract] [Full Text] [Related]
22. Effect of tenofovir on renal glomerular and tubular function.
Fux CA; Christen A; Zgraggen S; Mohaupt MG; Furrer H
AIDS; 2007 Jul; 21(11):1483-5. PubMed ID: 17589197
[TBL] [Abstract][Full Text] [Related]
23. Tenofovir and changes in renal function.
Flandre P
AIDS; 2010 Feb; 24(4):619-20. PubMed ID: 20195075
[No Abstract] [Full Text] [Related]
24. Renal safety of tenofovir disoproxil fumarate.
Sax PE; Gallant JE; Klotman PE
AIDS Read; 2007 Feb; 17(2):90-2, 99-104, C3. PubMed ID: 17323508
[TBL] [Abstract][Full Text] [Related]
25. Tenofovir-induced nephrotoxicity: myths and facts.
Gupta A; Bugeja A; Kirpalani D
Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):148-9. PubMed ID: 22237241
[No Abstract] [Full Text] [Related]
26. Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus.
Karras A; Lafaurie M; Furco A; Bourgarit A; Droz D; Sereni D; Legendre C; Martinez F; Molina JM
Clin Infect Dis; 2003 Apr; 36(8):1070-3. PubMed ID: 12684922
[TBL] [Abstract][Full Text] [Related]
27. Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndrome.
Brim NM; Cu-Uvin S; Hu SL; O'Bell JW
AIDS Read; 2007 Jun; 17(6):322-8, C3. PubMed ID: 17632940
[TBL] [Abstract][Full Text] [Related]
28. Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients.
Jaafar A; Séronie-Vivien S; Malard L; Massip P; Chatelut E; Tack I
AIDS; 2009 Jan; 23(2):257-9. PubMed ID: 19098496
[TBL] [Abstract][Full Text] [Related]
29. Increased beta-2 microglobulinuria in human immunodeficiency virus-1-infected children and adolescents treated with tenofovir.
Papaleo A; Warszawski J; Salomon R; Jullien V; Veber F; Dechaux M; Blanche S
Pediatr Infect Dis J; 2007 Oct; 26(10):949-51. PubMed ID: 17901802
[TBL] [Abstract][Full Text] [Related]
30. Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure.
Rifkin BS; Perazella MA
Am J Med; 2004 Aug; 117(4):282-4. PubMed ID: 15308442
[No Abstract] [Full Text] [Related]
31. Meeting notes from ICAAC. Tenofovir + ddI: a combination to avoid.
Sax PE
AIDS Clin Care; 2005 Jan; 17(1):6-7. PubMed ID: 15717372
[No Abstract] [Full Text] [Related]
32. CD4 cell decline with didanosine and tenofovir and failure of triple nucleoside/nucleotide regimens may be related.
Kakuda TN; Anderson PL; Becker SL
AIDS; 2004 Dec; 18(18):2442-4. PubMed ID: 15622326
[No Abstract] [Full Text] [Related]
33. Tenofovir/probenecid combination in HIV/HBV-coinfected patients: how to escape Fanconi syndrome recurrence?
Izzedine H; Thibault V; Valantin MA; Peytavin G; Schneider L; Benhamou Y
AIDS; 2010 Apr; 24(7):1078-9. PubMed ID: 20386378
[No Abstract] [Full Text] [Related]
34. Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1.
Breton G; Alexandre M; Duval X; Prie D; Peytavin G; Leport C; Vildei JL
Scand J Infect Dis; 2004; 36(6-7):527-8. PubMed ID: 15307594
[TBL] [Abstract][Full Text] [Related]
35. Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations.
Rodríguez-Nóvoa S; Labarga P; D'avolio A; Barreiro P; Albalate M; Vispo E; Solera C; Siccardi M; Bonora S; Di Perri G; Soriano V
AIDS; 2010 Apr; 24(7):1064-6. PubMed ID: 20299966
[TBL] [Abstract][Full Text] [Related]
36. [Renal adverse reactions of antiretroviral medication: proximal tubular dysfunction associated with tenofovir].
Kuijper A; Rookmaker MB; Mudrikova T
Ned Tijdschr Geneeskd; 2011; 155():A2249. PubMed ID: 21418698
[TBL] [Abstract][Full Text] [Related]
37. [Tenofovir associated hypokalaemia in a patient with normal renal function].
Elizalde A; Len O; Perelló M; Ribera E
Enferm Infecc Microbiol Clin; 2010 Nov; 28(9):655-6. PubMed ID: 20381923
[No Abstract] [Full Text] [Related]
38. Cutaneous reactions with tenofovir disoproxil fumarate: a report of nine cases.
Lockhart SM; Rathbun RC; Stephens JR; Baker DL; Drevets DA; Greenfield RA; Salvaggio MR; Vincent S
AIDS; 2007 Jun; 21(10):1370-3. PubMed ID: 17545718
[TBL] [Abstract][Full Text] [Related]
39. Fanconi syndrome and renal failure induced by tenofovir: a first case report.
Verhelst D; Monge M; Meynard JL; Fouqueray B; Mougenot B; Girard PM; Ronco P; Rossert J
Am J Kidney Dis; 2002 Dec; 40(6):1331-3. PubMed ID: 12460055
[TBL] [Abstract][Full Text] [Related]
40. Renal function in antiretroviral-experienced patients treated with tenofovir disoproxil fumarate associated with atazanavir/ritonavir.
Gérard L; Chazallon C; Taburet AM; Girard PM; Aboulker JP; Piketty C
Antivir Ther; 2007; 12(1):31-9. PubMed ID: 17503745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
